Study Reveals Rapid Prescriptions of ADHD Medication to Preschoolers Are Common and Often Contradict Guidelines
Many preschoolers diagnosed with ADHD are prescribed medication immediately, often contrary to treatment guidelines that recommend behavioral therapy first. A recent study underscores the need for better adherence to recommended practices and improved access to behavioral interventions.
Recent research led by Stanford Medicine highlights a concerning trend in the treatment of young children diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD). The study found that many preschoolers are being prescribed ADHD medications immediately following diagnosis, which conflicts with the treatment guidelines set by the American Academy of Pediatrics. According to the guidelines, children aged 4 and 5 should typically undergo at least six months of behavioral therapy before considering medication.
The investigation analyzed electronic health records from nearly 10,000 children across various U.S. pediatric care networks between 2016 and 2023. Results indicated that over 42% of children diagnosed with ADHD received medication within the first month, with only a small percentage (14.1%) starting medication after six months, as recommended. The study suggests that this rapid prescription pattern may be driven by systemic barriers, such as limited access to behavioral therapy options and insurance coverage issues, prompting doctors to opt for medication as a quicker solution.
The study's lead author, Dr. Yair Bannett, emphasized the importance of behavioral interventions, which can include parent training in behavior management to help children develop coping skills and routines. While medications can help alleviate symptoms like hyperactivity and inattentiveness, they can also cause side effects, especially in very young children whose bodies metabolize drugs differently.
Bannett pointed out that early effective treatment, combining behavioral strategies and medication when appropriate, can significantly improve academic outcomes and long-term life skills. He advocates for better access to behavioral therapy resources and increased awareness among pediatricians to ensure that treatment adheres to established guidelines, ultimately offering the best support for these young children.
Source: https://medicalxpress.com/news/2025-08-adhd-drugs-quickly-preschoolers.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Research Finds Sucrose Does Not Prevent Long-Term Developmental Effects in Preterm Infants Despite Pain Relief Use
Recent studies reveal that sucrose, widely used to soothe preterm infants during painful procedures, does not prevent long-term developmental challenges. Alternative pain management strategies are urgently needed to improve outcomes for these vulnerable babies.
Mushroom-Derived Compound Influences Gut Microbes Linked to Colorectal Cancer
A groundbreaking study reveals how a mushroom-derived antioxidant influences gut bacteria, unveiling new insights into colorectal cancer mechanisms and potential therapeutic targets.
New Neuroimaging Insights Reveal Iron and Myelin Deficiencies in Schizophrenia
New neuroimaging research identifies iron and myelin deficits in the brains of individuals with schizophrenia, offering insights into disease mechanisms and potential treatment targets.
Establishing a National Standard for Safe and Scalable AI in Healthcare
Duke University researchers have developed pioneering frameworks to evaluate the safety and performance of AI models in healthcare, advancing responsible AI adoption with scalable assessment tools for clinical settings.